1. P507 What is the impact of infliximab metaoptimisation on surgical rates and need-to-change-therapy in real-world practice for severe inflammatory bowel disease?. (16th January 2018) Authors: Lefebvre, T; Cormons, R; Faucheron, J -L; Baudrant, M; Bonaz, B; Mathieu, N Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S361 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P780 Interchangeability by a biosimilar of infliximab: What do patients think?. (16th January 2018) Authors: Baudrant, M; Roche, A; Allenet, B; Grange, L; Bouillet, L; Mathieu, N; Bonaz, B Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S504 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗